MESALAMINE | N022301 | SALIX PHARMACEUTICALS INC
| Trial # | Patent | Type | Petitioner | Status | Filed | Decision |
|---|---|---|---|---|---|---|
| IPR2016-01409 | 8865688 | IPR | MycoNovo, Inc. et al. | Terminated | 2016-07-11 | — |
| IPR2016-01386 | 8865688 | IPR | Mylan Pharmaceuticals Inc. et al. | Terminated | 2016-07-08 | — |
| IPR2016-00297 | 8865688 | IPR | GeneriCo, LLC et al. | Final Written Decision | 2015-12-08 | — |
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Salix Pharmaceuticals Inc. et al v. Novel Laboratories Inc. 4 patentsANDA 205841mesalamine | D. Del. | 2015-01-08 | Terminated 2017-07-31 | — |
| D. Del. | 2012-09-07 | Terminated 2014-09-16 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8865688 | May 1, 2030 | — | — | — | — |